A blocking peptide containing 15 amino acids near the extracellular domain of human APRIL.
Points forts
Source
Synthetic
(Accession #: NP_003799) The APRIL/TNFSF13 Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-053862 |
|---|
| Réf. fabricant | 18257087 |
|---|
| Gene ID (Entrez) | 8741 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-76767. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | A proliferation-inducing ligand, APRILFLJ57090, CD256, CD256 antigen, TALL2, TALL-2, TNF- and APOL-related leukocyte expressed ligand 2, TNF-related death ligand 1, TRDL-1, tumor necrosis factor (ligand) superfamily, member 13, tumor necrosis factor ligand superfamily member 13, tumor necrosis factor-like protein ZTNF2, tumor necrosis factor-related death ligand-1, ZTNF2 |
|---|
| Symbole de gène(s) | TNFSF13 |
|---|
| Type de produit | APRIL/TNFSF13 |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 15 amino acids near the extracellular domain of human APRIL |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
